• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雷莫司琼与咪达唑仑在 0.9%氯化钠注射液中用于术后恶心呕吐给药的稳定性和相容性。

Stability and Compatibility of Ramosetron with Midazolam in 0.9% Sodium Chloride Injection for Postoperative Nausea and Vomiting Administration.

机构信息

Department of Pharmacy, Wuhan Third Hospital, Tongren Hospital of Wuhan University, Wuhan, Hubei 430060, People's Republic of China.

Department of Pharmacy, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, People's Republic of China.

出版信息

Drug Des Devel Ther. 2020 Mar 17;14:1169-1176. doi: 10.2147/DDDT.S244439. eCollection 2020.

DOI:10.2147/DDDT.S244439
PMID:32256048
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7085948/
Abstract

BACKGROUND

Combination antiemetic therapy has become a common practice for the prevention of postoperative nausea and vomiting (PONV). The aim of the present study was to evaluate the stability and compatibility of ramosetron hydrochloride and midazolam in 0.9% sodium chloride injection when stored at 4°C and 25°C for up to 14 days.

METHODS

Admixtures were assessed initially and for 14 days after preparation in polyolefin bags and glass bottles using 0.9% sodium chloride injection as the diluent and stored at 4°C or 25°C. The initial concentrations were 0.3 mg/100 mL ramosetron hydrochloride and 0.5 mg/100 mL midazolam hydrochloride. For all samples, the compatibility parameters (including precipitation, cloudiness, discoloration and pH values) were evaluated. Chemical stability was also determined using high-performance liquid chromatography (HPLC) analysis.

RESULTS

After a 14-day period of storage at 4°C or 25°C, the percent of the initial concentration of ramosetron hydrochloride and midazolam hydrochloride in the various solutions were maintained at a minimum of 97%. All of the mixtures remained clear and colourless throughout the observation period, and no colour change or precipitation was observed.

CONCLUSION

The results indicate that admixtures of 0.3 mg/100 mL ramosetron hydrochloride and 0.5 mg/100 mL midazolam hydrochloride in normal saline were stable for 14 days at 4°C or 25°C when packaged in polyolefin bags or glass bottles and protected from light.

摘要

背景

联合止吐疗法已成为预防术后恶心和呕吐(PONV)的常见做法。本研究旨在评估盐酸雷莫司琼和咪达唑仑在 0.9%氯化钠注射液中在 4°C 和 25°C 下储存长达 14 天时的稳定性和相容性。

方法

将混合物在聚烯烃袋和玻璃瓶中用 0.9%氯化钠注射液作为稀释剂进行初始评估,并在 4°C 或 25°C 下储存 14 天。初始浓度为 0.3mg/100mL 盐酸雷莫司琼和 0.5mg/100mL 盐酸咪达唑仑。所有样品均评估了相容性参数(包括沉淀、浑浊、变色和 pH 值)。还使用高效液相色谱(HPLC)分析确定化学稳定性。

结果

在 4°C 或 25°C 下储存 14 天后,各溶液中盐酸雷莫司琼和盐酸咪达唑仑初始浓度的百分比均保持在 97%以上。在整个观察期间,所有混合物均保持澄清无色,未观察到颜色变化或沉淀。

结论

结果表明,在聚烯烃袋或玻璃瓶中包装并避光的情况下,0.3mg/100mL 盐酸雷莫司琼和 0.5mg/100mL 盐酸咪达唑仑在 0.9%氯化钠注射液中的混合物在 4°C 或 25°C 下可稳定 14 天。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b290/7085948/fb9d9a3060d3/DDDT-14-1169-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b290/7085948/e319cfebefc0/DDDT-14-1169-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b290/7085948/c1114debf680/DDDT-14-1169-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b290/7085948/1defb6647e34/DDDT-14-1169-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b290/7085948/fb9d9a3060d3/DDDT-14-1169-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b290/7085948/e319cfebefc0/DDDT-14-1169-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b290/7085948/c1114debf680/DDDT-14-1169-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b290/7085948/1defb6647e34/DDDT-14-1169-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b290/7085948/fb9d9a3060d3/DDDT-14-1169-g0004.jpg

相似文献

1
Stability and Compatibility of Ramosetron with Midazolam in 0.9% Sodium Chloride Injection for Postoperative Nausea and Vomiting Administration.雷莫司琼与咪达唑仑在 0.9%氯化钠注射液中用于术后恶心呕吐给药的稳定性和相容性。
Drug Des Devel Ther. 2020 Mar 17;14:1169-1176. doi: 10.2147/DDDT.S244439. eCollection 2020.
2
Physical compatibility and chemical stability of dezocine and ramosetron in 0.9% sodium chloride injection for patient-controlled analgesia administration.地佐辛和雷莫司琼在 0.9%氯化钠注射液中用于患者自控镇痛给药的物理相容性和化学稳定性。
Medicine (Baltimore). 2022 Nov 11;101(45):e31546. doi: 10.1097/MD.0000000000031546.
3
Comparison of ramosetron with combined ramosetron and midazolam for preventing postoperative nausea and vomiting in patients at high risk following laparoscopic gynaecological surgery.雷莫司琼与雷莫司琼联合咪达唑仑预防腹腔镜妇科手术后高危患者恶心呕吐的比较
J Int Med Res. 2013 Jun;41(3):654-63. doi: 10.1177/0300060513487627. Epub 2013 May 9.
4
Comparison of the antiemetic effect of ramosetron and combined ramosetron and midazolam in children: a double-blind, randomised clinical trial.雷莫司琼与雷莫司琼联合咪达唑仑预防儿童术后恶心呕吐的效果比较:一项双盲、随机临床试验。
Eur J Anaesthesiol. 2012 Apr;29(4):192-6. doi: 10.1097/EJA.0b013e32834fc1fb.
5
Compatibility and stability of dezocine and tropisetron in 0.9% sodium chloride injection for patient-controlled analgesia administration.地佐辛与托烷司琼在用于患者自控镇痛给药的0.9%氯化钠注射液中的配伍稳定性。
Medicine (Baltimore). 2018 Dec;97(50):e13698. doi: 10.1097/MD.0000000000013698.
6
Ramosetron, midazolam, and combination of ramosetron and midazolam for prevention of postoperative nausea and vomiting: a prospective, randomized, double-blind study.雷莫司琼、咪达唑仑及雷莫司琼与咪达唑仑联合用于预防术后恶心呕吐:一项前瞻性、随机、双盲研究。
J Int Med Res. 2013 Aug;41(4):1203-13. doi: 10.1177/0300060513485864. Epub 2013 Jun 13.
7
Physical Compatibility and Chemical Stability of Fentanyl and Naloxone Hydrochloride in 0.9% Sodium Chloride Injection Solution for Patient-Controlled Analgesia Administration.盐酸芬太尼和盐酸纳洛酮在 0.9%氯化钠注射液中用于患者自控镇痛给药的物理相容性和化学稳定性。
Drug Des Devel Ther. 2020 Oct 9;14:4179-4187. doi: 10.2147/DDDT.S248209. eCollection 2020.
8
Comparison of the antiemetic efficacy of a combination of midazolam with ramosetron and midazolam with palonosetron for postoperative nausea and vomiting prophylaxis in laparoscopic cholecystectomy.比较咪达唑仑联合雷莫司琼与咪达唑仑联合帕洛诺司琼预防腹腔镜胆囊切除术术后恶心呕吐的止吐效果。
Medicine (Baltimore). 2023 Dec 29;102(52):e36824. doi: 10.1097/MD.0000000000036824.
9
Compatibility and Stability of VARUBI (Rolapitant) Injectable Emulsion Admixed with Intravenous Granisetron Hydrochloride.盐酸伐柔比星(VARUBI)注射用乳剂与静脉注射用盐酸格拉司琼混合后的相容性和稳定性
Int J Pharm Compd. 2018 Jan-Feb;22(1):86-94.
10
Compatible stability of methylprednisolone sodium succinate and tropisetron in 0.9% sodium chloride injection.甲泼尼龙琥珀酸钠与托烷司琼在 0.9%氯化钠注射液中的配伍稳定性。
Eur J Hosp Pharm. 2020 Mar;27(e1):e58-e62. doi: 10.1136/ejhpharm-2018-001693. Epub 2018 Dec 1.

引用本文的文献

1
Physicochemical stability of mixtures of non-steroidal anti-inflammatory drugs such as ketorolac and diclofenac and antiemetics such as ondansetron and ramosetron: an study.酮咯酸和双氯芬酸等非甾体抗炎药与昂丹司琼和雷莫司琼等止吐药混合物的物理化学稳定性:一项研究。
Korean J Pain. 2025 Apr 1;38(2):103-115. doi: 10.3344/kjp.24316.
2
Ramosetron 3.0 μg/mL Combining with Dexamethasone (0.05, 0.1, 0.2 mg/mL) in Infusion Solutions: A Physicochemical Stability Study.雷莫司琼3.0μg/mL与地塞米松(0.05、0.1、0.2mg/mL)在输液中的联合应用:理化稳定性研究
Dose Response. 2024 Oct 14;22(4):15593258241293220. doi: 10.1177/15593258241293220. eCollection 2024 Oct-Dec.
3

本文引用的文献

1
Compatibility of dexamethasone sodium phosphate with 5-HT receptor antagonists in infusion solutions: a comprehensive study.地塞米松磷酸钠与输注液中5-羟色胺受体拮抗剂的相容性:一项全面研究。
Eur J Hosp Pharm. 2017 May;24(3):162-166. doi: 10.1136/ejhpharm-2016-000980. Epub 2016 Jul 14.
2
Compatibility and stability of dezocine and tropisetron in 0.9% sodium chloride injection for patient-controlled analgesia administration.地佐辛与托烷司琼在用于患者自控镇痛给药的0.9%氯化钠注射液中的配伍稳定性。
Medicine (Baltimore). 2018 Dec;97(50):e13698. doi: 10.1097/MD.0000000000013698.
3
Stability of azasetron-dexamethasone mixture for chemotherapy-induced nausea and vomiting administration.
Compatibility and stability of methylprednisolone sodium succinate and granisetron hydrochloride in 0.9% sodium chloride solution.
甲泼尼龙琥珀酸钠与盐酸格拉司琼在 0.9%氯化钠溶液中的配伍稳定性。
Medicine (Baltimore). 2022 Jul 15;101(28):e29674. doi: 10.1097/MD.0000000000029674.
阿扎司琼-地塞米松合剂用于化疗所致恶心和呕吐给药时的稳定性
Oncotarget. 2017 Oct 31;8(63):106249-106257. doi: 10.18632/oncotarget.22174. eCollection 2017 Dec 5.
4
Stability of Fentanyl Citrate, Hydromorphone Hydrochloride, Ketamine Hydrochloride, Midazolam, Morphine Sulfate, and Pentobarbital Sodium in Polypropylene Syringes.枸橼酸芬太尼、盐酸氢吗啡酮、盐酸氯胺酮、咪达唑仑、硫酸吗啡和戊巴比妥钠在聚丙烯注射器中的稳定性。
Pharmacy (Basel). 2015 Dec 16;3(4):379-385. doi: 10.3390/pharmacy3040379.
5
A Meta-Analysis of Palonosetron for the Prevention of Postoperative Nausea and Vomiting in Adults.帕洛诺司琼预防成人术后恶心呕吐的Meta分析
J Perianesth Nurs. 2015 Oct;30(5):398-405. doi: 10.1016/j.jopan.2015.05.116.
6
Dexmedetomidine added to an opioid-based analgesic regimen for the prevention of postoperative nausea and vomiting in highly susceptible patients: A randomised controlled trial.右美托咪定添加至基于阿片类药物的镇痛方案用于预防高度易感患者术后恶心呕吐:一项随机对照试验。
Eur J Anaesthesiol. 2016 Feb;33(2):75-83. doi: 10.1097/EJA.0000000000000327.
7
Ramosetron hydrochloride for the prevention of cancer chemotherapy induced nausea and vomiting: The Indian experience.盐酸雷莫司琼预防癌症化疗引起的恶心和呕吐:印度的经验。
South Asian J Cancer. 2014 Apr;3(2):132-7. doi: 10.4103/2278-330X.130466.
8
Intranasal dexmedetomidine vs midazolam for premedication in children undergoing complete dental rehabilitation: a double-blinded randomized controlled trial.鼻腔内给予右美托咪定与咪达唑仑用于接受全口牙齿修复的儿童术前用药:一项双盲随机对照试验。
Paediatr Anaesth. 2014 Feb;24(2):181-9. doi: 10.1111/pan.12287. Epub 2013 Nov 15.
9
Fosphenytoin y-site stability studies with Lorazepam and midazolam hydrochloride.磷苯妥英与劳拉西泮和盐酸咪达唑仑的Y型给药部位稳定性研究。
Int J Pharm Compd. 1999 May-Jun;3(3):235-8.
10
Ramosetron, midazolam, and combination of ramosetron and midazolam for prevention of postoperative nausea and vomiting: a prospective, randomized, double-blind study.雷莫司琼、咪达唑仑及雷莫司琼与咪达唑仑联合用于预防术后恶心呕吐:一项前瞻性、随机、双盲研究。
J Int Med Res. 2013 Aug;41(4):1203-13. doi: 10.1177/0300060513485864. Epub 2013 Jun 13.